Key gene found to drive kidney disease severity
- Date:
- July 31, 2015
- Source:
- Mount Sinai Medical Center
- Summary:
- Patients with higher levels of a key protein are at greater risk for severe kidney disease, experts report.
- Share:
Patients with higher levels of a key protein are at greater risk for severe kidney disease, according to a study published in Nature Communications and led by researchers from the Icahn School of Medicine at Mount Sinai. The study, which was conducted in mice, suggests that variations in the gene RTN1 led to greater production of the related RNT1 protein, which caused kidney cells to self-destruct.
"We are excited because these findings will shape our upcoming research efforts and hopefully lead to future classes of therapeutics," said John Cijiang He, MD, PhD, the Irene and Dr. Arthur M. Fishberg Professor of Medicine and Chief of the Division of Nephrology in the Department of Medicine at the Icahn School of Medicine at Mount Sinai. "We believe we have found a target for the development of drugs to prevent chronic kidney disease from becoming severe."
The findings contribute to a better understanding of kidney disease, which is commonly caused by diabetes, high blood pressure and cancer. When healthy, the kidneys filter blood, divert waste into urine and return useful proteins to the bloodstream. Chronic kidney disease (CKD) affects about 10 percent of American adults, and eventually progresses to end-stage renal disease that requires dialysis or a kidney transplant.
In the study, researchers found that when RTN1 gene is overexpressed, or activated more than normal, it causes an excess of a protein called reticulon to be built. This in turn changes the shape of the endoplasmic reticulum, part of the protein-building machinery in kidney cells, which signals cells to self-destruct as part of disease. The research team examined which genes were expressed more and less in study mice as kidney damage grew more severe. Genes whose level of expression correlated with the intensity of renal damage were catalogued, including RTN1. To ensure that the results were relevant to human kidney disease, researchers then confirmed that similar genetic differences are seen in human kidney disease. Before this study, RTN1 had never been examined in the context of kidney disease.
"Right now, therapeutic options for chronic kidney disease are limited, and only offer partial protection against disease protection," said Dr. He. "Therefore, there is an urgent need to identify key causes and mediators of chronic kidney disease progression so that we can find the best way to fight it."
Story Source:
Materials provided by Mount Sinai Medical Center. Note: Content may be edited for style and length.
Journal Reference:
- Ying Fan, Wenzhen Xiao, Zhengzhe Li, Xuezhu Li, Peter Y. Chuang, Belinda Jim, Weijia Zhang, Chengguo Wei, Niansong Wang, Weiping Jia, Huabao Xiong, Kyung Lee, John C. He. RTN1 mediates progression of kidney disease by inducing ER stress. Nature Communications, 2015; 6: 7841 DOI: 10.1038/ncomms8841
Cite This Page: